Bone marrow derived mesenchymal stem cells pretreated with erythropoietin accelerate the repair of acute kidney injury

Abstract Background Mesenchymal stem cells (MSCs) represent a promising treatment option for acute kidney injury (AKI). The main drawbacks of MSCs therapy, including the lack of specific homing after systemic infusion and early cell death in the inflammatory microenvironment, directly affect the the...

Full description

Saved in:
Bibliographic Details
Main Authors: Song Zhou, Yu-ming Qiao, Yong-guang Liu, Ding Liu, Jian-min Hu, Jun Liao, Min Li, Ying Guo, Li-pei Fan, Liu-Yang Li, Ming Zhao
Format: Artigo
Language:Inglês
Published: BMC 2020-11-01
Series:Cell & Bioscience
Subjects:
Acute kidney injury
Bone marrow derived mesenchymal stem cells
Erythropoietin
Lung entrapment
SIRT1
Online Access:http://link.springer.com/article/10.1186/s13578-020-00492-2
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items